PANDION THERAPEUTICS, INC. Operating Margin
- Operating margin · 12 months: Value -432.04%; Formula and calculation Operating income / revenue. Period ending 2020-12-31..
Operating margin
Overview →Financial period ending 2020-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -432.04% | Operating income / revenue. Period ending 2020-12-31. $-37.93M ÷ $8.78M × 100 ≈ -432.04% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -37.93M USD | Operating Income (Loss) |
| Revenue | 8.78M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | 33.91M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2020-12-31 | $-37.93M | $8.78M | (m) | $33.91M | (m) | -432.04% |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $-22.22M | $967.00K | (m) | $18.18M | (m) | -2297.72% |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.